Sign in

CIK 0001719406

  • Non-accelerated filer
  • Smaller reporting company

NRX Pharmaceuticals, Inc.

Sign in to watch
Ticker
NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
822844431
Phone
+1 484-254-6134
Business address
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
Former names
Big Rock Partners Acquisition Corp.
  1. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 50,000 shares at $1.17 ($58,500)
  2. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 30,000 shares at $1.10 ($33,000)
  3. 4/A Open-market buy CHIEF FINANCIAL OFFICER bought 16,337 shares at an average $1.11 ($18,215)
  4. 4 Open-market sale Director sold 400,000 shares at $1.00 ($400,000)
  5. 4 Open-market sale 10% owner sold 22,171 shares at an average $1.50 ($33,352)
  6. 4 Open-market buy Director bought 11,750 shares at an average $1.25 ($14,663)
  7. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 16,337 shares at an average $1.11 ($18,215)
  8. 4/A Open-market buy Director bought 500,000 shares at an average $1.03 ($514,905)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Director bought 500,000 shares at an average $1.03 ($514,905)
  13. 4 Open-market sale 10% owner sold 166,737 shares at an average $1.03 ($171,138)
  14. 4 Open-market sale 10% owner sold 49,200 shares at $1.01 ($49,510)
  15. 4 Open-market sale 10% owner sold 784,063 shares at $1.01 ($791,433)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Gift 10% owner gave 2,000,000 shares (gift)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale 10% owner sold 445,712 shares at an average $0.68 ($303,910)
  20. 4/A Open-market buy Chief Scientist bought 100,000 shares at $0.58 ($58,000)

Page 2 of 5 · 84 filings